2-32947599-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_206943.4(LTBP1):c.275G>A(p.Gly92Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000324 in 1,311,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_206943.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP1 | NM_206943.4 | c.275G>A | p.Gly92Asp | missense_variant | 1/34 | ENST00000404816.7 | NP_996826.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP1 | ENST00000404816.7 | c.275G>A | p.Gly92Asp | missense_variant | 1/34 | 5 | NM_206943.4 | ENSP00000386043 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000861 AC: 13AN: 151052Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000154 AC: 1AN: 6496Hom.: 0 AF XY: 0.000240 AC XY: 1AN XY: 4170
GnomAD4 exome AF: 0.000355 AC: 412AN: 1160874Hom.: 0 Cov.: 34 AF XY: 0.000324 AC XY: 183AN XY: 564226
GnomAD4 genome AF: 0.0000861 AC: 13AN: 151052Hom.: 0 Cov.: 32 AF XY: 0.0000950 AC XY: 7AN XY: 73720
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.275G>A (p.G92D) alteration is located in exon 1 (coding exon 1) of the LTBP1 gene. This alteration results from a G to A substitution at nucleotide position 275, causing the glycine (G) at amino acid position 92 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at